Tag: Fasinumab

Teva, Regeneron report positive data for fasinumab in phase 3 osteoarthritis trial

pharmanewsdaily- August 19, 2018

Teva Pharmaceutical Industries and Regeneron Pharmaceuticals said that a phase 3 study evaluating nerve growth factor (NGF) antibody fasinumab in patients with chronic pain from ... Read More